AGÕæÈ˹ٷ½

STOCK TITAN

[POS AM] Everi Holdings Inc SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
POS AM
Rhea-AI Filing Summary

Schedule 13D/A Amendment No. 6 for Gabelli Healthcare & Wellness Rx Trust (GRX) Preferred Shares discloses updated ownership information for multiple Gabelli-related entities and individuals.

Aggregate ownership: The Reporting Persons now hold 1,514,000 preferred shares, equal to 45.49 % of the 3,328,500 shares outstanding as of 30 Jun 2025. Key positions include:

  • Associated Capital Group (AC): 400,000 shares â€� 12.02 %
  • GAMCO Investors (GBL): 400,000 shares â€� 12.02 %
  • Mario J. Gabelli (individual): 400,000 shares â€� 12.02 %
  • Gabelli Foundation: 314,000 shares â€� 9.43 %

Recent transactions (26 Jun 2025): Several entities surrendered a total of 1,440,000 preferred shares (Series E & Series G) at $10.00 per share under the Fund’s put right to redeem up to 100 % of its outstanding cumulative preferred stock. The largest single surrender was 830,000 shares by Mario J. Gabelli.

Post-transaction, the group retains a controlling minority of the preferred class, maintaining significant influence over matters requiring preferred-shareholder approval. All reporting persons exercise sole voting and dispositive power over their respective holdings; no shared power is reported. No new legal proceedings or changes in control arrangements were disclosed.

Implications for investors: While the surrender materially reduces absolute ownership, the group’s collective stake remains large at 45 %. The buy-back at par ($10) may signal limited upside in the current preferred valuation and could affect liquidity of the remaining float. However, continued alignment of interests between the Gabelli entities and preferred shareholders persists.

Modifica Schedule 13D/A n. 6 per le Azioni Preferenziali di Gabelli Healthcare & Wellness Rx Trust (GRX) comunica informazioni aggiornate sulla proprietà di diverse entità e individui legati a Gabelli.

Proprietà complessiva: Le Persone Segnalanti detengono ora 1.514.000 azioni preferenziali, pari al 45,49% delle 3.328.500 azioni in circolazione al 30 giugno 2025. Le posizioni principali includono:

  • Associated Capital Group (AC): 400.000 azioni â€� 12,02%
  • GAMCO Investors (GBL): 400.000 azioni â€� 12,02%
  • Mario J. Gabelli (individuale): 400.000 azioni â€� 12,02%
  • Gabelli Foundation: 314.000 azioni â€� 9,43%

Transazioni recenti (26 giugno 2025): Diverse entità hanno restituito un totale di 1.440.000 azioni preferenziali (Serie E e Serie G) a 10,00 $ per azione esercitando il diritto di rimborso del Fondo fino al 100% delle azioni preferenziali cumulative in circolazione. La restituzione più grande è stata di 830.000 azioni da parte di Mario J. Gabelli.

Dopo la transazione, il gruppo mantiene una minoranza di controllo della classe preferenziale, conservando un’influenza significativa sulle decisioni che richiedono l’approvazione degli azionisti preferenziali. Tutte le persone segnalanti esercitano pieno potere di voto e decisionale sulle rispettive partecipazioni; non è segnalato alcun potere condiviso. Non sono state comunicate nuove procedure legali o modifiche negli accordi di controllo.

Implicazioni per gli investitori: Sebbene la restituzione riduca significativamente la proprietà assoluta, la quota collettiva del gruppo rimane elevata al 45%. Il riacquisto a valore nominale (10 $) potrebbe indicare un potenziale limitato nella valutazione attuale delle azioni preferenziali e influire sulla liquidità del flottante rimanente. Tuttavia, continua l’allineamento di interessi tra le entità Gabelli e gli azionisti preferenziali.

Enmienda No. 6 del Schedule 13D/A para las Acciones Preferentes de Gabelli Healthcare & Wellness Rx Trust (GRX) revela información actualizada sobre la propiedad de varias entidades e individuos relacionados con Gabelli.

Propiedad agregada: Las Personas Informantes ahora poseen 1,514,000 acciones preferentes, equivalentes al 45.49 % de las 3,328,500 acciones en circulación al 30 de junio de 2025. Las posiciones clave incluyen:

  • Associated Capital Group (AC): 400,000 acciones â€� 12.02 %
  • GAMCO Investors (GBL): 400,000 acciones â€� 12.02 %
  • Mario J. Gabelli (individual): 400,000 acciones â€� 12.02 %
  • Gabelli Foundation: 314,000 acciones â€� 9.43 %

Transacciones recientes (26 de junio de 2025): Varias entidades entregaron un total de 1,440,000 acciones preferentes (Series E y G) a $10.00 por acción bajo el derecho de redención del Fondo para recomprar hasta el 100% de sus acciones preferentes acumulativas en circulación. La entrega individual más grande fue de 830,000 acciones por Mario J. Gabelli.

Tras la transacción, el grupo conserva una minoría controladora de la clase preferente, manteniendo una influencia significativa sobre asuntos que requieren la aprobación de los accionistas preferentes. Todas las personas informantes ejercen poder exclusivo de voto y disposición sobre sus respectivas participaciones; no se reporta poder compartido. No se divulgaron nuevos procedimientos legales ni cambios en los acuerdos de control.

Implicaciones para los inversores: Aunque la entrega reduce materialmente la propiedad absoluta, la participación colectiva del grupo sigue siendo alta, con un 45 %. La recompra a valor nominal ($10) puede indicar un potencial limitado de apreciación en la valoración actual de las acciones preferentes y podría afectar la liquidez del flotante restante. Sin embargo, persiste la alineación de intereses entre las entidades Gabelli y los accionistas preferentes.

Gabelli Healthcare & Wellness Rx Trust (GRX) ìš°ì„ ì£¼ì— ëŒ€í•� Schedule 13D/A 수정ì•� 6í˜�ëŠ� Gabelli ê´€ë � 여러 ë²•ì¸ ë°� ê°œì¸ì� 소유ê¶� ì •ë³´ë¥� ì—…ë°ì´íŠ¸í•˜ì—¬ 공개합니ë‹�.

ì´� 소유 ì§€ë¶�: ë³´ê³ ìžë“¤ì€ 현재 1,514,000ì£� ìš°ì„ ì£�ë¥� 보유하고 있으ë©�, ì´ëŠ” 2025ë…� 6ì›� 30ì� 기준 발행 ì£¼ì‹ 3,328,500ì£¼ì˜ 45.49%ì—� 해당합니ë‹�. 주요 보유 ë‚´ì—­ì€ ë‹¤ìŒê³� 같습니다:

  • Associated Capital Group (AC): 400,000ì£� â€� 12.02%
  • GAMCO Investors (GBL): 400,000ì£� â€� 12.02%
  • Mario J. Gabelli (ê°œì¸): 400,000ì£� â€� 12.02%
  • Gabelli 재단: 314,000ì£� â€� 9.43%

최근 거래 ë‚´ì—­ (2025ë…� 6ì›� 26ì�): 여러 법ì¸ì� íŽ€ë“œì˜ í’‹ì˜µì…� 권리ë¥� 행사하여 1,440,000ì£� ìš°ì„ ì£�(E 시리ì¦� ë°� G 시리ì¦�)ë¥� 주당 $10.00ì—� 반환했습니다. ê°€ìž� í� ë‹¨ì¼ ë°˜í™˜ì€ Mario J. Gabelliì� 830,000ì£�옶Ä습니ë‹�.

거래 í›�, ê·¸ë£¹ì€ ìš°ì„ ì£� í´ëž˜ìŠ¤ì˜ ì§€ë°°ì  ì†Œìˆ˜ ì§€ë¶„ì„ ìœ ì§€í•˜ì—¬ 우선주주 ìŠ¹ì¸ ì‚¬í•­ì—� 대í•� ìƒë‹¹í•� ì˜í–¥ë ¥ì„ ê³„ì† í–‰ì‚¬í•©ë‹ˆë‹�. 모든 ë³´ê³ ìžëŠ” ê°ìžì� 보유 주ì‹ì—� 대í•� ë‹¨ë… ì˜ê²°ê¶� ë°� 처분ê¶�ì� 행사하며, ê³µë™ ê¶Œí•œì€ ë³´ê³ ë˜ì§€ 않았습니ë‹�. 새로ìš� ë²•ì  ì ˆì°¨ë‚� 지배구ì¡� ë³€ê²� ì‚¬í•­ì€ ê³µê°œë˜ì§€ 않았습니ë‹�.

투ìžìžì— 대í•� 시사ì �: 반환으로 절대 소유 ì§€ë¶„ì€ í¬ê²Œ 줄었지ë§�, 그룹ì� 집단 ì§€ë¶„ì€ ì—¬ì „íž� 45%ë¡� í½ë‹ˆë‹�. ì•¡ë©´ê°€($10)ë¡œì˜ ìžì‚¬ì£� ë§¤ìž…ì€ í˜„ìž¬ ìš°ì„ ì£� í‰ê°€ì—서 ìƒìй 여력ì� 제한ì ìž„ì� 시사í•� ìˆ� 있으ë©�, ë‚¨ì€ ìœ í†µ 주ì‹ì� 유ë™ì„±ì— ì˜í–¥ì� ì¤� ìˆ� 있습니다. 그러ë‚� Gabelli ê´€ë � 법ì¸ê³� 우선주주 ê°� ì´í•´ê´€ê³„ì˜ ì§€ì†ì ì� ì¼ì¹˜ëŠ� 유지ë©ë‹ˆë‹�.

Amendement n°6 du Schedule 13D/A concernant les Actions Préférentielles de Gabelli Healthcare & Wellness Rx Trust (GRX) révèle des informations mises à jour sur la propriété de plusieurs entités et individus liés à Gabelli.

Propriété agrégée : Les personnes déclarantes détiennent désormais 1 514 000 actions préférentielles, soit 45,49 % des 3 328 500 actions en circulation au 30 juin 2025. Les positions clés comprennent :

  • Associated Capital Group (AC) : 400 000 actions â€� 12,02 %
  • GAMCO Investors (GBL) : 400 000 actions â€� 12,02 %
  • Mario J. Gabelli (individu) : 400 000 actions â€� 12,02 %
  • Gabelli Foundation : 314 000 actions â€� 9,43 %

Transactions récentes (26 juin 2025) : Plusieurs entités ont cédé un total de 1 440 000 actions préférentielles (Séries E et G) au prix de 10,00 $ par action, en exerçant le droit de rachat du Fonds pouvant atteindre 100 % des actions préférentielles cumulatives en circulation. La plus grande cession individuelle a été de 830 000 actions par Mario J. Gabelli.

Après la transaction, le groupe conserve une minorité contrôlante de la catégorie préférentielle, maintenant une influence significative sur les questions nécessitant l'approbation des actionnaires préférentiels. Toutes les personnes déclarantes exercent un pouvoir exclusif de vote et de disposition sur leurs participations respectives ; aucun pouvoir partagé n’est signalé. Aucune nouvelle procédure judiciaire ni modification des accords de contrôle n’a été divulguée.

Implications pour les investisseurs : Bien que la cession réduise sensiblement la propriété absolue, la participation collective du groupe reste importante à 45 %. Le rachat à la valeur nominale (10 $) peut indiquer un potentiel limité de hausse dans l’évaluation actuelle des actions préférentielles et pourrait affecter la liquidité du flottant restant. Cependant, l’alignement continu des intérêts entre les entités Gabelli et les actionnaires préférentiels perdure.

Schedule 13D/A Änderung Nr. 6 für Gabelli Healthcare & Wellness Rx Trust (GRX) Vorzugsaktien legt aktualisierte Eigentumsinformationen für mehrere gabelli-bezogene Einheiten und Personen offen.

Gesamteigentum: Die meldenden Personen halten nun 1.514.000 Vorzugsaktien, was 45,49 % der 3.328.500 ausstehenden Aktien zum 30. Juni 2025 entspricht. Wichtige Positionen umfassen:

  • Associated Capital Group (AC): 400.000 Aktien â€� 12,02 %
  • GAMCO Investors (GBL): 400.000 Aktien â€� 12,02 %
  • Mario J. Gabelli (Einzelperson): 400.000 Aktien â€� 12,02 %
  • Gabelli Foundation: 314.000 Aktien â€� 9,43 %

Jüngste Transaktionen (26. Juni 2025): Mehrere Einheiten haben insgesamt 1.440.000 Vorzugsaktien (Serie E & Serie G) zum Preis von 10,00 $ pro Aktie im Rahmen des Rückkaufrechts des Fonds zurückgegeben, um bis zu 100 % der ausstehenden kumulativen Vorzugsaktien einzulösen. Die größte einzelne Rückgabe betrug 830.000 Aktien durch Mario J. Gabelli.

Nach der Transaktion behält die Gruppe eine kontrollierende Minderheit der Vorzugsaktienklasse und übt weiterhin erheblichen Einfluss auf Angelegenheiten aus, die die Zustimmung der Vorzugsaktionäre erfordern. Alle meldenden Personen üben alleinige Stimm- und Verfügungsgewalt über ihre jeweiligen Beteiligungen aus; eine gemeinsame Macht wurde nicht gemeldet. Es wurden keine neuen Rechtsverfahren oder Änderungen der Kontrollvereinbarungen offengelegt.

Auswirkungen für Anleger: Obwohl die Rückgabe den absoluten Besitz wesentlich reduziert, bleibt die kollektive Beteiligung der Gruppe mit 45 % hoch. Der Rückkauf zum Nennwert (10 $) könnte auf begrenztes Aufwärtspotenzial bei der aktuellen Vorzugsbewertung hinweisen und die Liquidität des verbleibenden Streubesitzes beeinflussen. Dennoch besteht weiterhin eine Interessenangleichung zwischen den Gabelli-Einheiten und den Vorzugsaktionären.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Gabelli entities cut preferred stake via fund put; still hold 45%, impact neutral.

The amendment shows a sizeable redemption�1.44 million shares—at $10.00, executed through the issuer’s contractual put right. Despite the reduction, the Gabelli complex maintains an influential 45% ownership. Redemption proceeds may reflect capital re-allocation rather than a bearish view, as the shares were put at mandatory terms, not open-market sales. No premium or discount was involved, limiting market-price signaling. Ownership concentration remains high, preserving potential board or voting leverage. Overall market impact is muted: free float increases modestly, but issuer cash outflow (not detailed here) may marginally pressure liquidity ratios. I assign a neutral (0) impact rating.

TL;DR: Large redemption improves holder liquidity but signals par-value ceiling.

The mass surrender implies holders preferred guaranteed par value over continued yield, suggesting limited upside in GRX preferreds above $10. The issuer’s willingness (or obligation) to redeem such volume indicates adequate cash or refinancing capacity, but investors should verify balance-sheet effects in subsequent filings. Remaining Gabelli alignment (45%) still supports governance continuity. From a portfolio perspective, this event is not a catalyst for common shares but worth monitoring for preferred liquidity and future coupon coverage. Rating 0 (neutral).

Modifica Schedule 13D/A n. 6 per le Azioni Preferenziali di Gabelli Healthcare & Wellness Rx Trust (GRX) comunica informazioni aggiornate sulla proprietà di diverse entità e individui legati a Gabelli.

Proprietà complessiva: Le Persone Segnalanti detengono ora 1.514.000 azioni preferenziali, pari al 45,49% delle 3.328.500 azioni in circolazione al 30 giugno 2025. Le posizioni principali includono:

  • Associated Capital Group (AC): 400.000 azioni â€� 12,02%
  • GAMCO Investors (GBL): 400.000 azioni â€� 12,02%
  • Mario J. Gabelli (individuale): 400.000 azioni â€� 12,02%
  • Gabelli Foundation: 314.000 azioni â€� 9,43%

Transazioni recenti (26 giugno 2025): Diverse entità hanno restituito un totale di 1.440.000 azioni preferenziali (Serie E e Serie G) a 10,00 $ per azione esercitando il diritto di rimborso del Fondo fino al 100% delle azioni preferenziali cumulative in circolazione. La restituzione più grande è stata di 830.000 azioni da parte di Mario J. Gabelli.

Dopo la transazione, il gruppo mantiene una minoranza di controllo della classe preferenziale, conservando un’influenza significativa sulle decisioni che richiedono l’approvazione degli azionisti preferenziali. Tutte le persone segnalanti esercitano pieno potere di voto e decisionale sulle rispettive partecipazioni; non è segnalato alcun potere condiviso. Non sono state comunicate nuove procedure legali o modifiche negli accordi di controllo.

Implicazioni per gli investitori: Sebbene la restituzione riduca significativamente la proprietà assoluta, la quota collettiva del gruppo rimane elevata al 45%. Il riacquisto a valore nominale (10 $) potrebbe indicare un potenziale limitato nella valutazione attuale delle azioni preferenziali e influire sulla liquidità del flottante rimanente. Tuttavia, continua l’allineamento di interessi tra le entità Gabelli e gli azionisti preferenziali.

Enmienda No. 6 del Schedule 13D/A para las Acciones Preferentes de Gabelli Healthcare & Wellness Rx Trust (GRX) revela información actualizada sobre la propiedad de varias entidades e individuos relacionados con Gabelli.

Propiedad agregada: Las Personas Informantes ahora poseen 1,514,000 acciones preferentes, equivalentes al 45.49 % de las 3,328,500 acciones en circulación al 30 de junio de 2025. Las posiciones clave incluyen:

  • Associated Capital Group (AC): 400,000 acciones â€� 12.02 %
  • GAMCO Investors (GBL): 400,000 acciones â€� 12.02 %
  • Mario J. Gabelli (individual): 400,000 acciones â€� 12.02 %
  • Gabelli Foundation: 314,000 acciones â€� 9.43 %

Transacciones recientes (26 de junio de 2025): Varias entidades entregaron un total de 1,440,000 acciones preferentes (Series E y G) a $10.00 por acción bajo el derecho de redención del Fondo para recomprar hasta el 100% de sus acciones preferentes acumulativas en circulación. La entrega individual más grande fue de 830,000 acciones por Mario J. Gabelli.

Tras la transacción, el grupo conserva una minoría controladora de la clase preferente, manteniendo una influencia significativa sobre asuntos que requieren la aprobación de los accionistas preferentes. Todas las personas informantes ejercen poder exclusivo de voto y disposición sobre sus respectivas participaciones; no se reporta poder compartido. No se divulgaron nuevos procedimientos legales ni cambios en los acuerdos de control.

Implicaciones para los inversores: Aunque la entrega reduce materialmente la propiedad absoluta, la participación colectiva del grupo sigue siendo alta, con un 45 %. La recompra a valor nominal ($10) puede indicar un potencial limitado de apreciación en la valoración actual de las acciones preferentes y podría afectar la liquidez del flotante restante. Sin embargo, persiste la alineación de intereses entre las entidades Gabelli y los accionistas preferentes.

Gabelli Healthcare & Wellness Rx Trust (GRX) ìš°ì„ ì£¼ì— ëŒ€í•� Schedule 13D/A 수정ì•� 6í˜�ëŠ� Gabelli ê´€ë � 여러 ë²•ì¸ ë°� ê°œì¸ì� 소유ê¶� ì •ë³´ë¥� ì—…ë°ì´íŠ¸í•˜ì—¬ 공개합니ë‹�.

ì´� 소유 ì§€ë¶�: ë³´ê³ ìžë“¤ì€ 현재 1,514,000ì£� ìš°ì„ ì£�ë¥� 보유하고 있으ë©�, ì´ëŠ” 2025ë…� 6ì›� 30ì� 기준 발행 ì£¼ì‹ 3,328,500ì£¼ì˜ 45.49%ì—� 해당합니ë‹�. 주요 보유 ë‚´ì—­ì€ ë‹¤ìŒê³� 같습니다:

  • Associated Capital Group (AC): 400,000ì£� â€� 12.02%
  • GAMCO Investors (GBL): 400,000ì£� â€� 12.02%
  • Mario J. Gabelli (ê°œì¸): 400,000ì£� â€� 12.02%
  • Gabelli 재단: 314,000ì£� â€� 9.43%

최근 거래 ë‚´ì—­ (2025ë…� 6ì›� 26ì�): 여러 법ì¸ì� íŽ€ë“œì˜ í’‹ì˜µì…� 권리ë¥� 행사하여 1,440,000ì£� ìš°ì„ ì£�(E 시리ì¦� ë°� G 시리ì¦�)ë¥� 주당 $10.00ì—� 반환했습니다. ê°€ìž� í� ë‹¨ì¼ ë°˜í™˜ì€ Mario J. Gabelliì� 830,000ì£�옶Ä습니ë‹�.

거래 í›�, ê·¸ë£¹ì€ ìš°ì„ ì£� í´ëž˜ìŠ¤ì˜ ì§€ë°°ì  ì†Œìˆ˜ ì§€ë¶„ì„ ìœ ì§€í•˜ì—¬ 우선주주 ìŠ¹ì¸ ì‚¬í•­ì—� 대í•� ìƒë‹¹í•� ì˜í–¥ë ¥ì„ ê³„ì† í–‰ì‚¬í•©ë‹ˆë‹�. 모든 ë³´ê³ ìžëŠ” ê°ìžì� 보유 주ì‹ì—� 대í•� ë‹¨ë… ì˜ê²°ê¶� ë°� 처분ê¶�ì� 행사하며, ê³µë™ ê¶Œí•œì€ ë³´ê³ ë˜ì§€ 않았습니ë‹�. 새로ìš� ë²•ì  ì ˆì°¨ë‚� 지배구ì¡� ë³€ê²� ì‚¬í•­ì€ ê³µê°œë˜ì§€ 않았습니ë‹�.

투ìžìžì— 대í•� 시사ì �: 반환으로 절대 소유 ì§€ë¶„ì€ í¬ê²Œ 줄었지ë§�, 그룹ì� 집단 ì§€ë¶„ì€ ì—¬ì „íž� 45%ë¡� í½ë‹ˆë‹�. ì•¡ë©´ê°€($10)ë¡œì˜ ìžì‚¬ì£� ë§¤ìž…ì€ í˜„ìž¬ ìš°ì„ ì£� í‰ê°€ì—서 ìƒìй 여력ì� 제한ì ìž„ì� 시사í•� ìˆ� 있으ë©�, ë‚¨ì€ ìœ í†µ 주ì‹ì� 유ë™ì„±ì— ì˜í–¥ì� ì¤� ìˆ� 있습니다. 그러ë‚� Gabelli ê´€ë � 법ì¸ê³� 우선주주 ê°� ì´í•´ê´€ê³„ì˜ ì§€ì†ì ì� ì¼ì¹˜ëŠ� 유지ë©ë‹ˆë‹�.

Amendement n°6 du Schedule 13D/A concernant les Actions Préférentielles de Gabelli Healthcare & Wellness Rx Trust (GRX) révèle des informations mises à jour sur la propriété de plusieurs entités et individus liés à Gabelli.

Propriété agrégée : Les personnes déclarantes détiennent désormais 1 514 000 actions préférentielles, soit 45,49 % des 3 328 500 actions en circulation au 30 juin 2025. Les positions clés comprennent :

  • Associated Capital Group (AC) : 400 000 actions â€� 12,02 %
  • GAMCO Investors (GBL) : 400 000 actions â€� 12,02 %
  • Mario J. Gabelli (individu) : 400 000 actions â€� 12,02 %
  • Gabelli Foundation : 314 000 actions â€� 9,43 %

Transactions récentes (26 juin 2025) : Plusieurs entités ont cédé un total de 1 440 000 actions préférentielles (Séries E et G) au prix de 10,00 $ par action, en exerçant le droit de rachat du Fonds pouvant atteindre 100 % des actions préférentielles cumulatives en circulation. La plus grande cession individuelle a été de 830 000 actions par Mario J. Gabelli.

Après la transaction, le groupe conserve une minorité contrôlante de la catégorie préférentielle, maintenant une influence significative sur les questions nécessitant l'approbation des actionnaires préférentiels. Toutes les personnes déclarantes exercent un pouvoir exclusif de vote et de disposition sur leurs participations respectives ; aucun pouvoir partagé n’est signalé. Aucune nouvelle procédure judiciaire ni modification des accords de contrôle n’a été divulguée.

Implications pour les investisseurs : Bien que la cession réduise sensiblement la propriété absolue, la participation collective du groupe reste importante à 45 %. Le rachat à la valeur nominale (10 $) peut indiquer un potentiel limité de hausse dans l’évaluation actuelle des actions préférentielles et pourrait affecter la liquidité du flottant restant. Cependant, l’alignement continu des intérêts entre les entités Gabelli et les actionnaires préférentiels perdure.

Schedule 13D/A Änderung Nr. 6 für Gabelli Healthcare & Wellness Rx Trust (GRX) Vorzugsaktien legt aktualisierte Eigentumsinformationen für mehrere gabelli-bezogene Einheiten und Personen offen.

Gesamteigentum: Die meldenden Personen halten nun 1.514.000 Vorzugsaktien, was 45,49 % der 3.328.500 ausstehenden Aktien zum 30. Juni 2025 entspricht. Wichtige Positionen umfassen:

  • Associated Capital Group (AC): 400.000 Aktien â€� 12,02 %
  • GAMCO Investors (GBL): 400.000 Aktien â€� 12,02 %
  • Mario J. Gabelli (Einzelperson): 400.000 Aktien â€� 12,02 %
  • Gabelli Foundation: 314.000 Aktien â€� 9,43 %

Jüngste Transaktionen (26. Juni 2025): Mehrere Einheiten haben insgesamt 1.440.000 Vorzugsaktien (Serie E & Serie G) zum Preis von 10,00 $ pro Aktie im Rahmen des Rückkaufrechts des Fonds zurückgegeben, um bis zu 100 % der ausstehenden kumulativen Vorzugsaktien einzulösen. Die größte einzelne Rückgabe betrug 830.000 Aktien durch Mario J. Gabelli.

Nach der Transaktion behält die Gruppe eine kontrollierende Minderheit der Vorzugsaktienklasse und übt weiterhin erheblichen Einfluss auf Angelegenheiten aus, die die Zustimmung der Vorzugsaktionäre erfordern. Alle meldenden Personen üben alleinige Stimm- und Verfügungsgewalt über ihre jeweiligen Beteiligungen aus; eine gemeinsame Macht wurde nicht gemeldet. Es wurden keine neuen Rechtsverfahren oder Änderungen der Kontrollvereinbarungen offengelegt.

Auswirkungen für Anleger: Obwohl die Rückgabe den absoluten Besitz wesentlich reduziert, bleibt die kollektive Beteiligung der Gruppe mit 45 % hoch. Der Rückkauf zum Nennwert (10 $) könnte auf begrenztes Aufwärtspotenzial bei der aktuellen Vorzugsbewertung hinweisen und die Liquidität des verbleibenden Streubesitzes beeinflussen. Dennoch besteht weiterhin eine Interessenangleichung zwischen den Gabelli-Einheiten und den Vorzugsaktionären.

As filed with the Securities and Exchange Commission on July 1, 2025

Registration No. 333- 235347    

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-3

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

EVERI HOLDINGS INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   20-0723270

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

7250 S. Tenaya Way

Suite 100

Las Vegas, Nevada 89113

(800) 833-7110

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

Mark F. Labay

Executive Vice President, Chief Financial Officer and Treasurer

Everi Holdings Inc.

7250 S. Tenaya Way, Suite 100

Las Vegas, Nevada 89113

(800) 833-7110

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copies to:

Davina K. Kaile

Pillsbury Winthrop Shaw Pittman LLP

2550 Hanover Street

Palo Alto, CA 94304-1115

Telephone: (650) 233-4500

 

 

Approximate date of commencement of proposed sale to the public: This post-effective amendment is being filed to deregister the unsold securities previously registered under this Registration Statement.

If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☐

If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

If this form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 
 


DEREGISTRATION OF SECURITIES

This Post-Effective Amendment No. 1 (the “Post-Effective Amendment”) relates to the Registration Statement on Form S-3 (No. 333-235347) of Everi Holdings Inc. (the “Registrant”), which was originally filed with the Securities and Exchange Commission and became automatically effective upon such filing on December 4, 2019, registering an indeterminate amount of (i) common stock, $0.001 par value per share (“Common Stock”); (ii) preferred stock, $0.001 par value per share; (iii) debt securities; (iv) warrants; and (v) units (collectively, the “Securities”) (the “Registration Statement”).

On July 1, 2025, pursuant to the terms and conditions of the previously disclosed definitive agreements executed on July 26, 2024 by and among the Registrant, International Game Technology PLC, a public limited company incorporated under the laws of England and Wales (“IGT”), Ignite Rotate LLC, a Delaware limited liability company and a direct wholly owned subsidiary of IGT (“Spinco”), Voyager Parent, LLC, a Delaware limited liability company owned by funds managed by affiliates of Apollo Global Management, Inc. (“Buyer”), and Voyager Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Buyer (“Buyer Sub,” and together with the Registrant, IGT, Spinco, and Buyer, the “Parties”), the Parties completed certain transactions, as a result of which, among other matters, Everi and IGT’s Gaming & Digital business were simultaneously acquired by Buyer.

Pursuant to the terms and subject to the conditions of the definitive agreements:

 

   

IGT transferred, or caused to be transferred, to Spinco substantially all of the assets, and Spinco assumed substantially all of the liabilities of IGT’s Gaming and Digital business (the “Separation”);

 

   

Immediately following the Separation and immediately prior to the consummation of the Merger (as defined below), (i) Buyer purchased from IGT, and IGT sold to Buyer, all of the outstanding units of Spinco (the “Equity Sale”); and (ii) Voyager Canada BidCo Limited, an affiliate of Buyer, purchased from IGT, and IGT sold to Voyager Canada BidCo Limited, all of the outstanding shares in the capital stock of IGT Canada Solutions ULC (the “Canada Sub Equity Interests Sale”); and

 

   

Immediately following the consummation of the Equity Sale and the Canada Sub Equity Interests Sale and at the effective time of the Merger (the “Merger Effective Time”):

 

   

Buyer Sub was merged with and into the Registrant, with the Registrant surviving the Merger as a direct wholly owned subsidiary of Buyer (the “Merger”).

As a result of the Merger and in connection with the delisting and the deregistration of the Registrant’s securities under Section 12(b) of the Securities Exchange Act of 1934, as amended, the Registrant is terminating all offerings of its securities pursuant to its existing registration statements under the Securities Act of 1933, as amended, including the Registration Statement. Pursuant to the undertaking made by the Registrant in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities that had been registered that remain unsold at the termination of the offering, the Registrant is filing this Post-Effective Amendment to terminate the effectiveness of such Registration Statement and to deregister, as of the effectiveness of this Post-Effective Amendment, any and all Securities registered thereunder that remain unsold as of the effectiveness date. Upon the effectiveness of this Post-Effective Amendment, no Securities will remain registered for sale pursuant to the Registration Statement.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Las Vegas, State of Nevada, on July 1, 2025.

 

EVERI HOLDINGS INC.
By:  

/s/ Mark F. Labay

 

Mark F. Labay

Executive Vice President, Chief Financial Officer and Treasurer


POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Randy L. Taylor, Mark F. Labay, and Todd A. Valli and each of them, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Post-Effective Amendment No. 1 to the Registration Statement and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Post-Effective Amendment No. 1 to the Registration Statement has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

 

Signature

  

Title

  

Date

/s/ RANDY L. TAYLOR    President and Chief Executive Officer and Director    July 1, 2025
Randy L. Taylor    (Principal Executive Officer)   
/s/ MARK F. LABAY    Executive Vice President, Chief Financial Officer    July 1, 2025
Mark F. Labay    (Principal Financial Officer) and Treasurer   
/s/ TODD A. VALLI    Senior Vice President, Chief Accounting Officer    July 1, 2025
Todd A. Valli    (Principal Accounting Officer)   
/s/ MICHAEL D. RUMBOLZ    Executive Chair of the Board    July 1, 2025
Michael D. Rumbolz    Director   
/s/ ATUL BALI    Lead Independent Director    July 1, 2025
Atul Bali      
/s/ GEOFFREY P. JUDGE    Director    July 1, 2025
Geoffrey P. Judge      
/s/ LINSTER W. FOX    Director    July 1, 2025
Linster W. Fox      
/s/ MAUREEN T. MULLARKEY    Director    July 1, 2025
Maureen T. Mullarkey      
/s/ SECIL TABLI WATSON    Director    July 1, 2025
Secil Tabli Watson      
/s/ PAUL FINCH    Director    July 1, 2025
Paul Finch      
/s/ DEBRA L. NUTTON    Director    July 1, 2025
Debra L. Nutton      
Everi Hldgs Inc

NYSE:EVRI

EVRI Rankings

EVRI Latest News

EVRI Latest SEC Filings

EVRI Stock Data

1.24B
83.69M
3.34%
88.99%
2.59%
Gambling
Services-miscellaneous Amusement & Recreation
United States
LAS VEGAS